Vir Biotechnology, Inc. (VIR) vs Xencor, Inc. (XNCR)
Vir Biotechnology, Inc. and Xencor, Inc. are both Biotechnology companies. Vir Biotechnology, Inc. and Xencor, Inc. are of similar size ($1.8B and $1.8B). Vir Biotechnology, Inc. grew revenue faster over the last twelve months: 1,495.9% against −28.6%. Vir Biotechnology, Inc. has the higher net margin (−83.0% vs −155.6%) and the higher return on invested capital (−39.1% vs −288.7%). Across the 16 metrics below, Vir Biotechnology, Inc. leads on 11 and Xencor, Inc. on 5.
Valuation
Profitability
| Metric | VIR | XNCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (92.40%) | (205.84%) | 0.00% |
| Net margin | (83.00%) | (155.59%) | 0.00% |
| Free cash flow margin | (67.17%) | (198.42%) | 0.00% |
| Return on equity | (26.08%) | (29.07%) | (57.72%) |
| Return on assets | (20.91%) | (20.36%) | (49.22%) |
| Return on invested capital | (39.10%) | (288.71%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack